Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Discontinued
Takeda Pharmaceutical Co. Ltd. (TKPYY) Terminates Development Of Top Prostate Cancer Prospect Orteronel 6/19/2014 6:09:16 AM
Johnson & Johnson (JNJ) Halts Development Of Botox Rival, Axes Staffers 4/14/2014 7:14:10 AM
Forest Laboratories, Inc. (FRX) To Discontinue NAMENDA® Tablets, Focus On Once-Daily NAMENDA XR® 2/17/2014 6:32:23 AM
Sanofi (France) (SAN.PA) Suffers Another Setback, Ditches Late-Stage Bone Marrow Cancer Drug 11/18/2013 7:03:54 AM
Imprimis Pharmaceuticals (immy) to Shift Focus, Discontinues Impracor Phase 3 Program to Focus on Other Areas 11/6/2013 9:06:43 AM
ImmunoGen, Inc. (IMGN) Discontinues Study as Lung Cancer Drug Flops; Stock Crashes -18.97%% at Market Close (November 5, 2013) 11/5/2013 7:22:00 AM
Ariad Pharmaceuticals, Inc. (ARIA) Discontinues Phase 3 Study of Cancer Drug Iclusig; Shares Decimated, Falls -40.67% at Market Close (October 18, 2013) 10/18/2013 8:07:51 AM
Medivir AB (MVIRb.F), Daewoong Pharmaceutical Co., Ltd. Discontinue Hepatitis B Drug Development 9/6/2013 6:54:34 AM
Medivir AB (MVIRb.F) Makes Strategic Decision to Discontinue its NS5A Inhibitor Program 8/15/2013 9:45:00 AM
Albany Molecular Research, Inc. (AMRI) (AMRI): Bristol-Myers Squibb Company (BMY) Stops Development of Depression Drug 8/13/2013 7:19:58 AM
Isis Pharmaceuticals, Inc. (ISIS) Ditches Rheumatoid Arthritis Drug After Phase 2 Trial Disappoints 8/5/2013 7:02:11 AM
Higher Death Rates Force Celgene Corporation (CELG) to End Blood Cancer Trial 7/18/2013 7:14:14 AM
Roche (RHHBY) Halts Diabetes Drug Trial in Blow to Pipeline 7/10/2013 7:37:31 AM
Roche (RHHBY) Backs Out on Seaside Therapeutics Drug Trial for Fragile X. Parents Dismayed 6/10/2013 7:59:45 AM
Sanofi (France) (SAN.PA) Pulls the Plug on Two Late-Stage Drugs, Plans $285 Million Charge 6/3/2013 7:59:51 AM
1234567
//-->